Sharechat Logo

Nufarm to raise A$300m in placement

Friday 15th May 2009

Text too small?

Nufarm, the farm chemicals company whose products include Roundup weed killer, plans to raise around A$300 million selling shares to institutions at a discount to repay debt.

The manufacturer is offering 26.7 million shares in an underwritten placement at A$11.25 apiece, a 9.9% discount to the last trading price.

Managing director Doug Rathbone will separately sell 1.75 million shares at the same price, raising A$19.7 million. He will remain the company’s largest shareholder, with about 11.3% after the transactions.

“The outlook for the global agriculture industry remains highly attractive and Nufarm is extremely well-placed to capitalise on additional opportunities as it pursues its growth strategy,” Rathbone said in a statement. The new capital “will result in lower debt, increased headroom under existing credit facilities, a stronger balance sheet and a reduced reliance on short-term financing requirements."

Shares of Nufarm have advanced 33% in the past three months though the shares peaked at A$18.33 in the past 12 months. The stock is rated ‘outperform’ based on the average of 10 estimates collated by Reuters. There were three ’buy’ ratings, four of ‘outperform’ and three of ‘hold.’

The shares are halted for the institutional placement today and will resume trading on May 18.

Nufarm’s forecast 2009 net debt will be about A$550 million after the placement while gearing will be 25% to-30%, it said.

The company today forecast full-year operating profit of A$220 million, with “strong sales demand” expected in the final three months of the year.The company also intends to offer shareholders a share purchase plan to subscribe for up to A$15,000 of shares. It gave no further details.

Businesswire.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors